Oncology Archives - Page 6 of 22

Cervical cancer screening guidelines and screening practices in 11 countries: a systematic literature review

Authors: W Wang, E Arcà, A Sinha, K Hartl, N Houwing, S Kothari Published: Preventative Medicine Reports, 2022 View publication Abstract The World Health Organization (WHO) advocates population-based screening programs to reduce...

Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain

Authors: J-Á Hernández-Rivas, M Arnao, J M A Pérez, A Rubio, E G García, D de Miguel, D Cherepanov, D Romanus, K Verleger, C Johnson, S L Corman, M Grande, E P...

Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study

Authors: S Beecroft, M O’Connell, A Nassar, K Noon, K G Pollock, D Palmer, T J S Cross Published: Frontline gastroenterology, 2022 View publication Objective Hepatocellular carcinoma (HCC) is increasingly incident in...

Implications of systemic adjuvant melanoma treatments for U.K. melanoma services: Results of the U.K. Melanoma Adjuvant Pathway Survey

Authors: O Cassell, C Harwood, M Hovey, M Payne Published: European Journal of Cancer Care, 2022 View publication Objective To understand current U.K. management pathways for patients with resected stage III melanoma...

Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England

Authors: Svenja Petersohn 1, Gilles Salles 2, Michael Wang 3, Jim Wu 4, Sally W Wade 5, Claire L Simons 6, Craig Bennison 6, Rubina Siddiqi 4, Weimin Peng 4, Ioana Kloos...

A quality-adjusted survival time without symptom or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy

Authors: C T Solem, T J Bell, Y Kwon, J C Cappelleri, C Johnson, H Bhattacharyya, C J Hoang, J E Cortes Published: Cancer, 2020 View publication Background In a randomized study,...

A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands

Authors: S Claudiani, J J W M Janssen, J Byrne, G Smith, N Blijlevens, M Raghavan, M Smith, R E Clark, S Mclain-Smith, A M Carter, D Milojkovic, J F Apperley Published:...

A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study

Authors: A J Mead, N M Butt, W Nagi, A Whiteway, S Kirkpatrick, C Rinaldi, C Roughley, S Ackroyd, J Ewing, P Neelakantan, M Garg, D Tucker, J Murphy, H Patel, R...

A guide to selecting flexible survival models to inform economic evaluations of cancer immunotherapies

Authors: S Palmer, I Borget, T Friede, D Husereau, J Karnon, B Kearns, E Medin, E F P Peterse, S L Klijn, E J M Verburg-Baltussen, E Fenwick, J Borrill Published: Value...

News